-
公开(公告)号：KR1020110017660A
公开(公告)日：2011-02-22
申请号：KR1020090075242
申请日：2009-08-14
Applicant: (주)아모레퍼시픽
IPC: A61K8/97 , A61Q19/02 , A23L1/30 , A61K36/254
CPC classification number: A61K8/97 , A23L33/105 , A61K36/254 , A61Q19/02 , Y10S514/859
Abstract: PURPOSE: A composition containing Acanthopanax senticosus extract is provided to suppress pigmentation by acne and to be sued in cosmetic product or medical field. CONSTITUTION: A composition for suppressing pigmentation by acne contains Acanthopanax senticosus extract as an active ingredient. The Acanthopanax senticosus extract is isolated using distilled water and C1-C5 organic solvent of hydrous or anhydrous low alcohol. An external use composition contains the composition for suppressing acne. The conten of the Acanthopanax senticosus extract is contained 0.5-20 weight% based on total weight. The external use skin composition is a cosmetic formulation.
Abstract translation: 目的：提供含有刺五加提取物的组合物，以抑制痤疮的色素沉着，并在化妆品或医疗领域起诉。 构成：抑制痤疮色素沉着的组合物含有刺五加提取物作为活性成分。 使用蒸馏水和含水或无水低醇的C1-C5有机溶剂分离刺五加提取物。 外用组合物含有抑制痤疮的组合物。 刺五加提取物的含量为0.5-20重量％，基于总重量。 外用皮肤组合物是化妆品制剂。
-
公开(公告)号：KR1020110017645A
公开(公告)日：2011-02-22
申请号：KR1020090075219
申请日：2009-08-14
Applicant: (주)아모레퍼시픽
IPC: A61K8/97 , A61Q19/02 , A23L1/30 , A61K36/708
Abstract: PURPOSE: A composition containing Rheum undulatum extract is provided to suppress pigmentation due to acne and to be used in a cosmetic field or medical field. CONSTITUTION: A composition for suppressing pigmentation due to acne contains Rheum undulatum extract as an active ingredient. An external use skin composition contains the composition for suppressing pigmentation. The content of the Rheum undulatum extract is 0.5-20 weight%. The composition is a cosmetic formulation. An aftercare composition for acne contains Rheum undulatum extract as an active ingredient.
Abstract translation: 目的：提供含有大黄精华提取物的组合物以抑制由于痤疮引起的色素沉着并用于化妆品领域或医疗领域。 构成：用于抑制由于痤疮引起的色素沉着的组合物含有作为有效成分的无色杜鹃花提取物。 外用皮肤组合物含有抑制色素沉着的组合物。 大黄精华提取物的含量为0.5〜20重量％。 组合物是化妆品制剂。 用于痤疮的保健用组合物含有作为活性成分的大黄精华提取物。
-
公开(公告)号：KR1020110017566A
公开(公告)日：2011-02-22
申请号：KR1020090075085
申请日：2009-08-14
Applicant: (주)아모레퍼시픽
IPC: A61K8/97 , A61Q19/02 , A23L1/30 , A61K36/738
Abstract: PURPOSE: A composition containing Rosa spp. extract is provided to suppress pigmentation by acne and to be used in food or cosmetic field. CONSTITUTION: A composition for suppressing pigmentation by acne contains 0.5-20 weight% of Rosa spp. extract as an active ingredient. An external use skin composition contains the composition for suppressing pigmentation. The composition is a cosmetic formulation. A food additive or health food composition contains the composition for suppressing pigmentation or aftercare composition.
Abstract translation: 目的：含有罗莎属的组合物。 提取物以抑制痤疮的色素沉着，并用于食品或化妆品领域。 构成：用于抑制痤疮色素沉着的组合物含有0.5-20重量％的罗莎属。 提取物作为活性成分。 外用皮肤组合物含有抑制色素沉着的组合物。 组合物是化妆品制剂。 食品添加剂或保健食品组合物含有抑制色素沉着或后处理组合物的组合物。
-
公开(公告)号：KR1020110017563A
公开(公告)日：2011-02-22
申请号：KR1020090075082
申请日：2009-08-14
Applicant: (주)아모레퍼시픽
IPC: A61K8/97 , A61Q19/02 , A23L1/30 , A61K36/481
Abstract: PURPOSE: A composition containing Astraglus membranaceus extract is provided to prevent acne pigmentation and/or scar and to be used in cosmetic, food, or medial field. CONSTITUTION: A composition for suppressing acne pigmentation contains Astraglus membranaceus extract as an active ingredient. The Astraglus membranaceus extract suppresses gelatinase. The composition is used in the form of cosmetic product. A composition for aftercare of acne contains Astraglus membranaceus extract as an active ingredient. A food additive or health food contains Astraglus membranaceus extract.
Abstract translation: 目的：提供含有黄芪提取物的组合物，以防止痤疮色素沉着和/或疤痕，并用于化妆品，食品或内部领域。 构成：抑制痤疮色素沉着的组合物含有黄芪提取物作为活性成分。 黄芪提取物抑制明胶酶。 该组合物以化妆品的形式使用。 用于治疗痤疮的组合物含有黄芪提取物作为活性成分。 食品添加剂或保健食品含有黄芪提取物。
-
公开(公告)号：KR1020100122455A
公开(公告)日：2010-11-22
申请号：KR1020100043804
申请日：2010-05-11
Applicant: (주)아모레퍼시픽
CPC classification number: A61K31/19 , A23L33/10 , A23V2002/00 , A61K8/361 , A61Q7/00 , A23V2200/318
Abstract: PURPOSE: A composition containing valproic acid for promoting hair growth or preventing hair loss is provided to apply in pharmaceutical and cosmetic field. CONSTITUTION: A composition for preventing hair loss or promoting hair growth contains valproic acid or pharmaceutically acceptable salt thereof as an active ingredient. The salt is sodium valproate. The composition is manufactured in a percutaneous administration. The composition is also manufactured hypodermic injection or external use formulation. A pharmaceutical or cosmetic composition contains the composition for preventing hair loss or promoting hair growth.
Abstract translation: 目的：提供一种用于促进头发生长或预防脱发的含有丙戊酸的组合物，用于制药和美容领域。 构成：用于预防脱发或促进毛发生长的组合物含有丙戊酸或其药学上可接受的盐作为活性成分。 盐是丙戊酸钠。 组合物经皮给药制成。 该组合物还制造皮下注射或外用制剂。 药物或化妆品组合物含有用于防止脱发或促进毛发生长的组合物。
-
Patent Agency Ranking
公开(公告)号：KR1020100103670A
公开(公告)日：2010-09-27
申请号：KR1020107017553
申请日：2008-12-03
Applicant: (주)아모레퍼시픽
CPC classification number: A61K31/15
Abstract: PURPOSE: A slimming cosmetic composition containing 2-cyclopentene-1-one oxime derivative is provided to promote lipid lysis in adipocytes(3T3-L1) and to reduce body fat. CONSTITUTION: A slimming cosmetic composition contains 2-cyclopentene-1-one oxime derivatives compound of chemical formula 1 or pharmaceutically acceptable salt as an active ingredient. The cosmetic composition induces decrease of neutral fat by promoting lipid lysis. The cosmetic composition is used in the form of emulsion, lotion, cream, gel, oil, spray, ointment, powder, compact, pack cleanser, shampoo, rinse, patch, or pad.
Abstract translation: 目的：提供含有2-环戊烯-1-酮肟衍生物的减肥美容组合物，以促进脂肪细胞（3T3-L1）中的脂质溶解，并减少体脂肪。 构成：减肥化妆品组合物含有化学式1的2-环戊烯-1-酮肟衍生物化合物或其药学上可接受的盐作为活性成分。 化妆品组合物通过促进脂质溶解诱导中性脂肪的减少。 化妆品组合物以乳液，洗剂，霜剂，凝胶，油，喷雾剂，软膏剂，粉剂，紧凑型包装清洁剂，洗发剂，漂洗剂，补片或垫片的形式使用。
-
公开(公告)号：KR1020100026835A
公开(公告)日：2010-03-10
申请号：KR1020080085990
申请日：2008-09-01
Applicant: (주)아모레퍼시픽
IPC: A61K31/353 , A61P29/00
Abstract: PURPOSE: An anti-inflammatory composition containing acid polysaccharide of green tea is provided to relieve skin irritation, pruritus, and inflammation and to treat and prevent inflammatory dermatitis. CONSTITUTION: An acid polysaccharide having a function of suppressing inflammation is isolated from green tea. The acid polysaccharide is isolated by extracting with hot water and performing ultrafiltration and ethanol precipitation. The acid polysaccharide is rhamnose, arabinose, ribose, xylose, glucose, mannose and D-galactose. A pharmaceutical composition for preventing or treating inflammatory dermatitis contains 0.05-50 weight% of acid polysaccharide as an active ingredient. A cosmetic composition having function of suppressing inflammation contains 0.05-5 weight% of acid polysaccharide based on total weight. The cosmetic composition is used in the form of skin softener, nutrition lotion, massage cream, moisture cream, nutrition cream, pack, gel, body lotion, body cream, body oil, shampoo, and body cleanser.
Abstract translation: 目的：提供含有绿茶酸多糖的抗炎组合物，以缓解皮肤刺激，瘙痒和炎症，并治疗和预防炎症性皮炎。 构成：从绿茶中分离具有抑制炎症功能的酸性多糖。 酸性多糖用热水提取分离，进行超滤和乙醇沉淀。 酸多糖是鼠李糖，阿拉伯糖，核糖，木糖，葡萄糖，甘露糖和D-半乳糖。 用于预防或治疗炎性皮炎的药物组合物含有0.05-50重量％的酸性多糖作为活性成分。 具有抑制炎症功能的化妆品组合物含有0.05-5重量％的基于总重量的酸性多糖。 化妆品组合物以皮肤柔软剂，营养乳液，按摩霜，防湿霜，营养霜，包装，凝胶，身体乳液，身体霜，人体油，洗发剂和身体清洁剂的形式使用。
-
公开(公告)号：KR100879423B1
公开(公告)日：2009-01-19
申请号：KR1020077011568
申请日：2005-11-30
Applicant: (주)아모레퍼시픽
IPC: C07C251/44 , C07C251/32
CPC classification number: C07C317/32 , C07C251/44 , C07C255/61 , C07C259/18 , C07C323/47 , C07C2601/08 , C07C2601/10 , C07C2601/14 , C07D209/08 , C07D213/53 , C07D307/91 , C07D317/58 , C07D333/22 , C07D333/58 , C07D339/08
Abstract: 화학식 1로 나타내어지는 2-사이클로펜텐-1-온 옥심 유도체, 또는 그의 약학적으로 허용가능한 염은 TNF-α 또는 PDE4의 생산을 저해함으로써 TNF-α 또는 PDE4를 통해 매개된 염증성 또는 면역성 질환들에 대한 치료효과를 나타낸다.
-
公开(公告)号：KR100709014B1
公开(公告)日：2007-04-18
申请号：KR1020050078835
申请日：2005-08-26
Applicant: (주)아모레퍼시픽
Inventor： 서영거 , 오우택 , 김희두 , 이지우 , 박형근 , 박옥희 , 이용실 , 박영호 , 주영협 , 최진규 , 임경민 , 김선영 , 김진관 , 고현주 , 모주현 , 정연수 , 이정범 , 오영임
IPC: A61K31/17
CPC classification number: C07D333/42 , C07C311/08 , C07C311/47 , C07C333/20 , C07C335/12 , C07C335/14 , C07C335/20 , C07C335/26 , C07C2601/14 , C07C2602/10 , C07D207/323 , C07D207/416 , C07D207/42 , C07D209/08 , C07D209/14 , C07D213/40 , C07D213/61 , C07D213/76 , C07D217/06 , C07D231/14 , C07D231/56 , C07D233/64 , C07D235/14 , C07D239/42 , C07D241/12 , C07D241/24 , C07D277/28 , C07D295/13 , C07D295/215 , C07D295/32 , C07D307/52 , C07D311/58 , C07D317/58 , C07D333/20
Abstract: 본 발명은 바닐로이드 수용체(Vanilloid Receptor; VR)에 대한 조절제로서 신규한 티오우레아 유도체를 함유하는 약제학적 조성물에 관한 것이다.
바닐로이드 수용체의 활성과 연관된 질환에는 통증, 급성 통증, 만성 통증, 신경병적 통증, 수술후 통증, 편두통, 관절통, 신경병증, 신경손상, 당뇨병성 신경병, 신경변성 질환, 신경성 피부질환, 뇌졸중, 방광과민증, 과민성 장증후군, 천식과 만성폐색성 폐질환등 호흡기 이상, 피부, 눈, 점막의 자극, 발열, 위-십이지장궤양, 염증성 장 질환 및 염증성 질환 등이 포함될 수 있다. 본 발명은 이들 질환의 예방, 치료를 위한 약제학적 조성물을 제공한다.
바닐로이드 수용체, 티오우레아 유도체, 통증, 염증, 궤양-
90.发明公开바닐로이드 수용체의 강력한 길항제로서 사용하는 신규한화합물 또는 약제학적으로 허용가능한 그의 염； 및 이를함유하는 약제학적 조성물 有权新型化合物或药物作为耐药性VANILLOID受体拮抗剂的接受口服; 和含有它们的药物组合物
公开(公告)号：KR1020060096326A
公开(公告)日：2006-09-11
申请号：KR1020060019873
申请日：2006-03-02
Applicant: (주)아모레퍼시픽
IPC: C07D213/36 , C07D213/61 , C07C233/64
Abstract: 본 발명은 바닐로이드 수용체 (Vanilloid Receptor 1 ; VR1 ; TRPV1)의 길항제로서 신규한 화합물 또는 약제학적으로 허용가능한 그의 염; 및 이를 함유하는 약제학적 조성물에 관한 것이다.
본 발명의 화합물 또는 조성물은 통증, 편두통, 관절통, 신경통, 신경병증, 신경손상, 피부질환, 과민성방광, 과민성대장증후군, 변실금, 호흡기질환, 피부, 눈 또는 점막의 자극, 위십이지장궤양, 염증성질환, 이(耳)질환, 및 심장질환 등의 예방 및 치료에 유용하다.
바닐로이드 수용체 길항제, N-페닐벤즈아마이드 유도체
-
-
-
-
-
-
-
-
-
Search Results
91
records
(took 0.033 seconds)
